Cite
Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia
MLA
Tanaka, Satomi, et al. “Ezh2 Augments Leukemogenicity by Reinforcing Differentiation Blockage in Acute Myeloid Leukemia.” Blood, vol. 120, no. 5, Aug. 2012, pp. 1107–17. EBSCOhost, https://doi.org/10.1182/blood-2011-11-394932.
APA
Tanaka, S., Miyagi, S., Sashida, G., Chiba, T., Yuan, J., Mochizuki-Kashio, M., Suzuki, Y., Sugano, S., Nakaseko, C., Yokote, K., Koseki, H., & Iwama, A. (2012). Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia. Blood, 120(5), 1107–1117. https://doi.org/10.1182/blood-2011-11-394932
Chicago
Tanaka, Satomi, Satoru Miyagi, Goro Sashida, Tetsuhiro Chiba, Jin Yuan, Makiko Mochizuki-Kashio, Yutaka Suzuki, et al. 2012. “Ezh2 Augments Leukemogenicity by Reinforcing Differentiation Blockage in Acute Myeloid Leukemia.” Blood 120 (5): 1107–17. doi:10.1182/blood-2011-11-394932.